Efficacy of Favipiravir Against Severe Ebola Virus Disease
Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore the therapeutic efficacy of Favipiravir, a
broad-spectrum antiviral drug against severe cases of Ebola Virus Disease (EVD), which is the
most difficult aspect for clinical management of EVD due to its high fatality rate.
Phase:
Phase 2
Details
Lead Sponsor:
Beijing Institute of Pharmacology and Toxicology
Collaborators:
307 Hospital of PLA Beijing 302 Hospital Centers for Disease Control and Prevention, China Sierra Leone-China Friendship Hospital